These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 6090665

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Analogues of caffeine and theophylline: effect of structural alterations on affinity at adenosine receptors.
    Daly JW, Padgett WL, Shamim MT.
    J Med Chem; 1986 Jul; 29(7):1305-8. PubMed ID: 3806581
    [Abstract] [Full Text] [Related]

  • 3. Analogues of 1,3-dipropyl-8-phenylxanthine: enhancement of selectivity at A1-adenosine receptors by aryl substituents.
    Daly JW, Padgett WL, Shamim MT.
    J Med Chem; 1986 Aug; 29(8):1520-4. PubMed ID: 3016270
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Functionalized congeners of 1,3-dialkylxanthines: preparation of analogues with high affinity for adenosine receptors.
    Jacobson KA, Kirk KL, Padgett WL, Daly JW.
    J Med Chem; 1985 Sep; 28(9):1334-40. PubMed ID: 2993622
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Trifunctional agents as a design strategy for tailoring ligand properties: irreversible inhibitors of A1 adenosine receptors.
    Boring DL, Ji XD, Zimmet J, Taylor KE, Stiles GL, Jacobson KA.
    Bioconjug Chem; 1991 Sep; 2(2):77-88. PubMed ID: 1868116
    [Abstract] [Full Text] [Related]

  • 8. Linear and proximal benzo-separated alkylated xanthines as adenosine-receptor antagonists.
    Schneller SW, Ibay AC, Christ WJ, Bruns RF.
    J Med Chem; 1989 Oct; 32(10):2247-54. PubMed ID: 2795597
    [Abstract] [Full Text] [Related]

  • 9. Species differences in structure-activity relationships of adenosine agonists and xanthine antagonists at brain A1 adenosine receptors.
    Ukena D, Jacobson KA, Padgett WL, Ayala C, Shamim MT, Kirk KL, Olsson RO, Daly JW.
    FEBS Lett; 1986 Dec 01; 209(1):122-8. PubMed ID: 3803571
    [Abstract] [Full Text] [Related]

  • 10. Adenosine receptor binding: structure-activity analysis generates extremely potent xanthine antagonists.
    Bruns RF, Daly JW, Snyder SH.
    Proc Natl Acad Sci U S A; 1983 Apr 01; 80(7):2077-80. PubMed ID: 6300892
    [Abstract] [Full Text] [Related]

  • 11. 4-Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants.
    Sarges R, Howard HR, Browne RG, Lebel LA, Seymour PA, Koe BK.
    J Med Chem; 1990 Aug 01; 33(8):2240-54. PubMed ID: 2374150
    [Abstract] [Full Text] [Related]

  • 12. A functionalized congener approach to adenosine receptor antagonists: amino acid conjugates of 1,3-dipropylxanthine.
    Jacobson KA, Kirk KL, Padgett WL, Daly JW.
    Mol Pharmacol; 1986 Feb 01; 29(2):126-33. PubMed ID: 3005825
    [Abstract] [Full Text] [Related]

  • 13. Effects of 8-phenyl and 8-cycloalkyl substituents on the activity of mono-, di-, and trisubstituted alkylxanthines with substitution at the 1-, 3-, and 7-positions.
    Shamim MT, Ukena D, Padgett WL, Daly JW.
    J Med Chem; 1989 Jun 01; 32(6):1231-7. PubMed ID: 2724296
    [Abstract] [Full Text] [Related]

  • 14. Structure-activity relationships of 8-styrylxanthines as A2-selective adenosine antagonists.
    Jacobson KA, Gallo-Rodriguez C, Melman N, Fischer B, Maillard M, van Bergen A, van Galen PJ, Karton Y.
    J Med Chem; 1993 May 14; 36(10):1333-42. PubMed ID: 8496902
    [Abstract] [Full Text] [Related]

  • 15. Interaction of anticonvulsant drugs with adenosine receptors in the central nervous system.
    Weir RL, Padgett W, Daly JW, Anderson SM.
    Epilepsia; 1984 Aug 14; 25(4):492-8. PubMed ID: 6086302
    [Abstract] [Full Text] [Related]

  • 16. Xanthine derivatives as adenosine receptor antagonists.
    Fredholm BB, Persson CG.
    Eur J Pharmacol; 1982 Jul 30; 81(4):673-6. PubMed ID: 6288418
    [Abstract] [Full Text] [Related]

  • 17. 1,3,8-trisubstituted xanthines. Effects of substitution pattern upon adenosine receptor A1/A2 affinity.
    Erickson RH, Hiner RN, Feeney SW, Blake PR, Rzeszotarski WJ, Hicks RP, Costello DG, Abreu ME.
    J Med Chem; 1991 Apr 30; 34(4):1431-5. PubMed ID: 2016719
    [Abstract] [Full Text] [Related]

  • 18. Structure-activity relationships of 8-cycloalkyl-1,3-dipropylxanthines as antagonists of adenosine receptors.
    Katsushima T, Nieves L, Wells JN.
    J Med Chem; 1990 Jul 30; 33(7):1906-10. PubMed ID: 1694546
    [Abstract] [Full Text] [Related]

  • 19. Sulfur-containing 1,3-dialkylxanthine derivatives as selective antagonists at A1-adenosine receptors.
    Jacobson KA, Kiriasis L, Barone S, Bradbury BJ, Kammula U, Campagne JM, Secunda S, Daly JW, Neumeyer JL, Pfleiderer W.
    J Med Chem; 1989 Aug 30; 32(8):1873-9. PubMed ID: 2754711
    [Abstract] [Full Text] [Related]

  • 20. 8-Polycycloalkyl-1,3-dipropylxanthines as potent and selective antagonists for A1-adenosine receptors.
    Shimada J, Suzuki F, Nonaka H, Ishii A.
    J Med Chem; 1992 Mar 06; 35(5):924-30. PubMed ID: 1548682
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.